Focus Partners Advisor Solutions’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
Focus Partners Advisor Solutions's NVCR Position: Q3 2026 in Review
Focus Partners Advisor Solutions opened a new position in NovoCure (NVCR) in Q3 2026: 10,838 shares worth $173K. The stake represents ﹤0.01% of the portfolio and ranks #1308 among its holdings.
242 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.
- Focus Partners Advisor Solutions held 10,838 shares of NovoCure worth $173K as of Q3 2026.
- NovoCure was a new Focus Partners Advisor Solutions position in Q3 2026.
- NovoCure made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q3 2026, its #1308 holding.
- 242 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q3 2026, filed 10 Nov 2026.